iifl-logo
  • testing
  • |

iifl-logo

Senores Pharmaceuticals Ltd Board Meeting

542.05
(1.31%)
Jun 10, 2025|12:00:00 AM

CORPORATE ACTIONS

03/07/2024calendar-icon
03/07/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting2 Jun 20252 Jun 2025
Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on June 02, 2025.
Board Meeting15 May 20259 May 2025
Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31 2025; and to transact any other business matters. Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 15, 2025. (As Per BSE Announcement Dated on :15.05.2025)
Board Meeting23 Jan 202510 Jan 2025
Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve Unaudited and Consolidated Financial Results of the Company for quarter and nine months ended December 31 2024 and to transact any other business matters. Outcome of Board Meeting Senores Pharmaceuticals Ltd has informed BSE regarding Appointment of Secretarial Auditor for FY 2024_]2025 Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024. (As Per BSE Announcement Dated on 23/01/2025)

Senores Pharmaceuticals Ltd: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

testing
  • testing
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

testing
  • testing
  • testing

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.